
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early and long term antibody kinetics of asymptomatic and mild disease COVID-19 patients
Shai Efrati, Merav Catalogna, Ramzia Abu Hamed, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Shai Efrati, Merav Catalogna, Ramzia Abu Hamed, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 14
Showing 14 citing articles:
Antibody Duration After Infection From SARS-CoV-2 in the Texas Coronavirus Antibody Response Survey
Michael D. Swartz, Stacia M. DeSantis, Ashraf Yaseen, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 2, pp. 193-201
Open Access | Times Cited: 46
Michael D. Swartz, Stacia M. DeSantis, Ashraf Yaseen, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 2, pp. 193-201
Open Access | Times Cited: 46
The Sexual Long COVID (SLC): Erectile Dysfunction as a Biomarker of Systemic Complications for COVID-19 Long Haulers
Andrea Sansone, Daniele Mollaioli, Erika Limoncin, et al.
Sexual Medicine Reviews (2021) Vol. 10, Iss. 2, pp. 271-285
Open Access | Times Cited: 53
Andrea Sansone, Daniele Mollaioli, Erika Limoncin, et al.
Sexual Medicine Reviews (2021) Vol. 10, Iss. 2, pp. 271-285
Open Access | Times Cited: 53
Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals
Mohammad Al‐Tamimi, Amjed A. Tarifi, Arwa Qaqish, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281689-e0281689
Open Access | Times Cited: 17
Mohammad Al‐Tamimi, Amjed A. Tarifi, Arwa Qaqish, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281689-e0281689
Open Access | Times Cited: 17
Risk factors for worsening of somatic symptom burden in a prospective cohort during the COVID-19 pandemic
Petra Engelmann, Bernd Löwe, Thomas Theo Brehm, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 23
Petra Engelmann, Bernd Löwe, Thomas Theo Brehm, et al.
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 23
Probing SARS-CoV-2-positive plasma to identify potential factors correlating with mild COVID-19 in Ghana, West Africa
Kesego Tapela, Fatima Oyawoye, Charles Ochieng’ Olwal, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Kesego Tapela, Fatima Oyawoye, Charles Ochieng’ Olwal, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 12
Longevity and Neutralizing Capacity of IgG Antibodies against SARS-CoV-2 Generated by the Application of BNT162b2, AZD1222, Convidecia, Sputnik V, and CoronaVac Vaccines: a Cohort Study in the Mexican Population
Larissa Fernandes-Matano, Ángel Gustavo Salas-Lais, Concepción Grajales-Muñíz, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 5
Larissa Fernandes-Matano, Ángel Gustavo Salas-Lais, Concepción Grajales-Muñíz, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 5
IgA quantification as a good predictor of the neutralizing antibodies levels after vaccination against SARS-CoV-2
Lorena O. Fernandes-Siqueira, Bruna G. Sousa, Carlos E. Cleto, et al.
Journal of Clinical Virology Plus (2022) Vol. 2, Iss. 4, pp. 100121-100121
Open Access | Times Cited: 8
Lorena O. Fernandes-Siqueira, Bruna G. Sousa, Carlos E. Cleto, et al.
Journal of Clinical Virology Plus (2022) Vol. 2, Iss. 4, pp. 100121-100121
Open Access | Times Cited: 8
Plausible mechanism of drug resistance and side-effects of COVID-19 therapeutics: a bottleneck for its eradication
S. Das, Sreyashi Nath, Shahjahan, et al.
DARU Journal of Pharmaceutical Sciences (2024) Vol. 32, Iss. 2, pp. 801-823
Closed Access | Times Cited: 1
S. Das, Sreyashi Nath, Shahjahan, et al.
DARU Journal of Pharmaceutical Sciences (2024) Vol. 32, Iss. 2, pp. 801-823
Closed Access | Times Cited: 1
Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period
Catherine Lazor‐Blanchet, Panagiota Zygoura, Urania Dafni, et al.
Journal of Infection (2022) Vol. 84, Iss. 5, pp. 722-746
Open Access | Times Cited: 3
Catherine Lazor‐Blanchet, Panagiota Zygoura, Urania Dafni, et al.
Journal of Infection (2022) Vol. 84, Iss. 5, pp. 722-746
Open Access | Times Cited: 3
COVID-19 IgG antibodies detection based on CNN-BiLSTM algorithm combined with fiber-optic dataset
Mohammed Jawad Ahmed Alathari, Yousif Al Mashhadany, Ahmad Ashrif A. Bakar, et al.
Journal of Virological Methods (2024) Vol. 330, pp. 115011-115011
Closed Access
Mohammed Jawad Ahmed Alathari, Yousif Al Mashhadany, Ahmad Ashrif A. Bakar, et al.
Journal of Virological Methods (2024) Vol. 330, pp. 115011-115011
Closed Access
Assessment of Neutralizing Antibodies Against COVID-19: The Impact of Vaccination in Western Rajasthan
Varsha Choudhary, Prabhat Kiran Khatri, Palak Khinvasara, et al.
Indian Journal of Clinical Biochemistry (2024)
Closed Access
Varsha Choudhary, Prabhat Kiran Khatri, Palak Khinvasara, et al.
Indian Journal of Clinical Biochemistry (2024)
Closed Access
The levels of SARS-CoV-2 IgG antibody and cytokine profile in blood serum of young people during the COVID-19 pandemic
Yu. А. Li, M. N. Dmitrachenko, E. V. Markelova, et al.
Medical Immunology (Russia) (2024) Vol. 27, Iss. 2, pp. 369-378
Open Access
Yu. А. Li, M. N. Dmitrachenko, E. V. Markelova, et al.
Medical Immunology (Russia) (2024) Vol. 27, Iss. 2, pp. 369-378
Open Access
Laboratory Findings in Different Disease Status of COVID-19 Admitted Patients at Dilla University Referral Hospital Treatment Center, South Ethiopia
Gemechu Churiso, Kuma Diriba, Henok Girma, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 4307-4320
Open Access | Times Cited: 1
Gemechu Churiso, Kuma Diriba, Henok Girma, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 4307-4320
Open Access | Times Cited: 1
Antibody dynamics and viral load in COVID-19: differences in mild, moderate and severe cases
Kim Ngoc, Iva Trifonova, Iva Christova, et al.
Biotechnology & Biotechnological Equipment (2023) Vol. 37, Iss. 1
Open Access
Kim Ngoc, Iva Trifonova, Iva Christova, et al.
Biotechnology & Biotechnological Equipment (2023) Vol. 37, Iss. 1
Open Access